[HTML][HTML] Review of key knowledge gaps in glucose-6-phosphate dehydrogenase deficiency detection with regard to the safe clinical deployment of 8-aminoquinoline …

L Von Seidlein, S Auburn, F Espino, D Shanks… - Malaria journal, 2013 - Springer
The diagnosis and management of glucose-6-phosphate dehydrogenase (G6PD) deficiency
is a crucial aspect in the current phases of malaria control and elimination, which will require …

[HTML][HTML] Evaluation of a novel quantitative test for glucose-6-phosphate dehydrogenase deficiency: bringing quantitative testing for glucose-6-phosphate …

S Pal, P Bansil, G Bancone, S Hrutkay… - The American journal …, 2019 - ncbi.nlm.nih.gov
Glucose-6-phosphate dehydrogenase (G6PD) deficiency, a common genetic blood
condition, can result in kernicterus at birth, and later in life as severe hemolysis on exposure …

[HTML][HTML] Population screening for glucose-6-phosphate dehydrogenase deficiency using quantitative point-of-care tests: a systematic review

MAH Zailani, RZA Raja Sabudin, A Ithnin… - Frontiers in …, 2023 - frontiersin.org
Background: Glucose-6-phosphate dehydrogenase (G6PD) deficiency is an X-linked
hereditary disorder and a global public health concern that is most prevalent in malaria …

[HTML][HTML] Glucose-6-phosphate dehydrogenase deficiency in people living in malaria endemic districts of Nepal

P Ghimire, N Singh, L Ortega, KR Rijal, B Adhikari… - Malaria journal, 2017 - Springer
Abstract Background Glucose-6-phosphate dehydrogenase (G6PD) is a rate limiting
enzyme of the pentose phosphate pathway and is closely associated with the haemolytic …

[HTML][HTML] Glucose-6-phosphate dehydrogenase deficiency among malaria suspects attending Gambella hospital, southwest Ethiopia

A Tsegaye, L Golassa, H Mamo, B Erko - Malaria journal, 2014 - Springer
Background Glucose-6-phosphate dehydrogenase deficiency (G6PDd) is widespread
across malaria endemic regions. G6PD-deficient individuals are at risk of haemolysis when …

[HTML][HTML] Assessment of glucose-6-phosphate dehydrogenase activity using CareStart G6PD rapid diagnostic test and associated genetic variants in Plasmodium vivax …

OKM Djigo, MA Bollahi, M Hasni Ebou… - PLoS …, 2019 - journals.plos.org
Background Primaquine is recommended by the World Health Organization (WHO) for
radical treatment of Plasmodium vivax malaria. This drug is known to provoke acute …

[HTML][HTML] Population screening for glucose-6-phosphate dehydrogenase deficiencies in Isabel Province, Solomon Islands, using a modified enzyme assay on filter …

M Kuwahata, R Wijesinghe, MF Ho, A Pelecanos… - Malaria journal, 2010 - Springer
Background Glucose-6-phosphate dehydrogenase deficiency poses a significant
impediment to primaquine use for the elimination of liver stage infection with Plasmodium …

[HTML][HTML] Performance of the CareStart glucose-6-phosphate dehydrogenase (G6PD) rapid diagnostic test in Gressier, Haiti

ME von Fricken, TA Weppelmann… - The American journal …, 2014 - ncbi.nlm.nih.gov
Administering primaquine (PQ) to treat malaria patients with glucose-6-phosphate
dehydrogenase (G6PD) deficiency can pose a serious risk of drug-induced hemolysis (DIH) …

Assessment of CareStart G6PD rapid diagnostic test and CareStart G6PD biosensor in Mauritania

OKM Djigo, YO Khalef, MSOA Salem… - Infectious Diseases of …, 2021 - mednexus.org
Background: The elimination of Plasmodium vivax malaria requires 8-aminoquinolines,
which are contraindicated in patients with glucose-6-phosphate dehydrogenase (G6PD) …

Rapid epidemiologic assessment of glucose‐6‐phosphate dehydrogenase deficiency in malaria‐endemic areas in Southeast Asia using a novel diagnostic kit

A Jalloh, IS Tantular, S Pusarawati… - Tropical Medicine & …, 2004 - Wiley Online Library
We recently reported a new rapid screening method for glucose‐6‐phosphate
dehydrogenase (G6PD) deficiency. This method incorporates a new formazan substrate …